Grace Karugaba
Overview
Explore the profile of Grace Karugaba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karugaba G, Thupayagale-Tshweneagae G, Moleki M, Matshaba M
PLoS One
. 2023 Apr;
18(4):e0284467.
PMID: 37099531
Background: Due to antiretroviral therapy, many people with perinatally acquired HIV are surviving into young adulthood which is a critical period of human development. Research conducted in various settings globally...
2.
Karugaba G, Simpson J, Mathuba B, Phoi O, Regonamanye T, Mathuba K, et al.
PLoS One
. 2022 Aug;
17(8):e0273777.
PMID: 36044527
Background: Despite high rates of HIV testing and enrolment of HIV-positive pregnant women on antiretroviral therapy in Botswana, coverage for HIV-exposed infant (HEI) testing remains suboptimal. Many factors can contribute...
3.
Karugaba G, Thupayagale-Tshweneagae G, Moleki M, Mabikwa O, Matshaba M
South Afr J HIV Med
. 2022 Jun;
23(1):1362.
PMID: 35706544
Background: Due to the successful antiretroviral therapy (ART) programme in Botswana, large numbers of perinatally HIV-infected adolescents are emerging into young adulthood. Young adulthood is a critical period of human...
4.
Anabwani G, Karugaba G, Gabaitiri L
BMC Pediatr
. 2016 Aug;
16(1):132.
PMID: 27542913
No abstract available.
5.
Anabwani G, Karugaba G, Gabaitiri L
BMC Pediatr
. 2016 Jul;
16:106.
PMID: 27449750
Background: Antiretroviral treatment means many HIV infected children are surviving with a highly stigmatised condition. There is a paucity of data to inform policies for this growing cohort. Hence we...